Recruiting
Phase 1
Phase 2

Atomoxetine & DAW2022

Sponsor:

Brigham and Women's Hospital

Code:

NCT05350215

Conditions

Obstructive Sleep Apnea

Eligibility Criteria

Sex: All

Age: 21 - 70

Healthy Volunteers: Not accepted

Interventions

Placebo oral capsule

Atomoxetine Oral Capsule [Strattera]

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2023-07-07.